First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined all- and auto-immune tumor reactivity
V.E.J.C. Schijns*, C. Pretto, L. Devillers, D. Pierre, F.M. Hofman, T.C. Chen, P. Mespouille, P. Hantos, P. Glorieux, D.A. Bota, A. Stathopolous*
Dive into the research topics of 'First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined all- and auto-immune tumor reactivity'. Together they form a unique fingerprint.